share_log

Credit Suisse Maintains Underperform on Clover Health Investments, Lowers Price Target to $1.25

Benzinga ·  Mar 6, 2023 07:31

Credit Suisse analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Underperform and lowers the price target from $2.5 to $1.25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment